diclofenac has been researched along with Rectal Neoplasms in 1 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Rectal Neoplasms: Tumors or cancer of the RECTUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The results of this study are in line with other comparable studies in the literature, showing an increased risk for anastomotic leakage with diclofenac." | 3.83 | Risk of anastomotic leakage with nonsteroidal anti-inflammatory drugs within an enhanced recovery program. ( Bakker, N; Cakir, H; Deelder, JD; Doodeman, HJ; Houdijk, AP; Richir, MC; Schreurs, WH, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakker, N | 1 |
| Deelder, JD | 1 |
| Richir, MC | 1 |
| Cakir, H | 1 |
| Doodeman, HJ | 1 |
| Schreurs, WH | 1 |
| Houdijk, AP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects on Omission of NSAIDs on the Consumption of Opioids in the Standard Analgesic Regimen After Elective Laparoscopic Colorectal Cancer Resection in an ERAS Setting. A Retrospective Single-center Cohort Study.[NCT04448652] | 502 participants (Actual) | Observational [Patient Registry] | 2015-01-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for diclofenac and Rectal Neoplasms
| Article | Year |
|---|---|
Risk of anastomotic leakage with nonsteroidal anti-inflammatory drugs within an enhanced recovery program.
Topics: Aged; Aged, 80 and over; Anastomosis, Surgical; Anastomotic Leak; Anti-Inflammatory Agents, Non-Ster | 2016 |